US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

4.67

-0.5300-10.19%

Volume:287.16K

Turnover:1.30M

Market Cap:7.05M

PE:-0.12

High:4.80

Open:4.80

Low:4.26

Close:5.20

52wk High:59.70

52wk Low:1.51

Shares:1.51M

Float Shares:725.94K

Volume Ratio:0.02

T/O Rate:39.56%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-38.5450

EPS(LYR):-0.1759

ROE:-144.99%

ROA:-69.29%

PB:0.86

PE(LYR):-26.55

Loading ...

Overview Company News Filings

Business Combinations

Form 425 - Prospectuses and communications, business combinations

Major Issues Report

Form 8-K/A - Current report: [Amend]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K/A - Current report: [Amend]

Business Combinations

Form 425 - Prospectuses and communications, business combinations

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/APUS/filings?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":4.67,"timestamp":1791918806560,"preClose":5.2,"halted":0,"volume":287157,"delay":0,"changeRate":-0.10192307692307696,"floatShares":725942,"shares":1509119,"eps":-38.545,"marketStatus":"Trading","change":-0.53,"latestTime":"10-13 15:13:46 EDT","open":4.8,"high":4.8,"low":4.26,"amount":1297194.3309429,"amplitude":0.103846,"askPrice":4.81,"askSize":100,"bidPrice":4.55,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-38.545,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":5.2,"preHourTrading":{"tag":"盘前","latestPrice":4.9112,"preClose":5.2,"latestTime":"09:27 EDT","volume":13388,"amount":66298.1752636,"timestamp":1791898048254,"change":-0.2888,"changeRate":-0.055538,"amplitude":0.075},"postHourTrading":{"tag":"盘后","latestPrice":5.02,"preClose":5.2,"latestTime":"19:59 EDT","volume":30868,"amount":157290.7748,"timestamp":1791849585519,"change":-0.18,"changeRate":-0.034615,"amplitude":0.038462},"volumeRatio":0.022578},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":725942,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":0.022578,"shares":1509119,"dividePrice":0,"high":4.8,"amplitude":0.103846,"preClose":5.2,"low":4.26,"week52Low":1.51,"pbRate":"0.86","week52High":59.7,"institutionHeld":0,"latestPrice":4.67,"eps":-38.545,"divideRate":0,"volume":287157,"delay":0,"ttmEps":-38.545,"open":4.8,"prevYearClose":16.4,"prevWeekClose":5.02,"prevMonthClose":5,"prevQuarterClose":5,"fiveDayClose":7.13,"twentyDayClose":1.64,"sixtyDayClose":6.467},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-24","symbol":"APUS","defaultRemindTime":1784899800000,"type":"split","dateTimestamp":1784865600000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-0.121157,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1791918826475},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"APUS\",pageSize:20,pageCount:2,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"20744148","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026017331-APUS","pdf_url":"","pub_time":1771363918000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"APUS","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"Business Combinations","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-017331-index.html","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 2 TO FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017331/ea0277267-8ka2_api.htm","primary":true,"translateUrl":"","linkName":"ea0277267-8ka2_api.htm","type":"425","id":"NTFILEDi2Wnf8XB59PFJPU","market":"us","size":28296},{"description":"UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2025, AND FOR TH","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017331/ea027726701ex99-1_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-1_api.htm","type":"EX-99.1","id":"NTFILEGGFK5SaXjmzoh31z","market":"us","size":164577},{"description":"AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED MARCH 31, 2025 AND","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017331/ea027726701ex99-2_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-2_api.htm","type":"EX-99.2","id":"NTFILEFyb6eeG14Q9xtfUZ","market":"us","size":167378},{"description":"UNAUDITED PROFORMA CONSOLIDATED FINANCIAL INFORMATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017331/ea027726701ex99-3_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-3_api.htm","type":"EX-99.3","id":"NTFILEBJWTu76qbJHpkoPG","market":"us","size":94139}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Business Combinations","pubTime":"2026-02-18 05:31","pubTimestamp":1771363918,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20744182","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026017323-APUS","pdf_url":"","pub_time":1771363828000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"APUS","title":"Form 8-K/A - Current report: [Amend]","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-017323-index.html","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 2 TO FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea0277267-8ka2_api.htm","primary":true,"translateUrl":"","linkName":"ea0277267-8ka2_api.htm","type":"8-K/A","id":"NTFILE9BYLZYNBr4hUb6TN","market":"us","size":33151},{"description":"UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2025, AND FOR TH","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea027726701ex99-1_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-1_api.htm","type":"EX-99.1","id":"NTFILEEmjEcULRxUu9Nu7m","market":"us","size":164577},{"description":"AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED MARCH 31, 2025 AND","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea027726701ex99-2_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-2_api.htm","type":"EX-99.2","id":"NTFILEH9NPma2AZzkzwiy3","market":"us","size":167378},{"description":"UNAUDITED PROFORMA CONSOLIDATED FINANCIAL INFORMATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea027726701ex99-3_api.htm","primary":false,"translateUrl":"","linkName":"ea027726701ex99-3_api.htm","type":"EX-99.3","id":"NTFILEHXNc7TeMG7VdL6fZ","market":"us","size":94139}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-02-18 05:30","pubTimestamp":1771363828,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20594368","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026000464-APUS","pdf_url":"","pub_time":1767330000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026000464/0001213900-26-000464-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026000464/ea0271636-8k_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0271636-8k_apimeds.htm","type":"8-K","id":"NTFILEHY4Xbr2NsH1Jo9Zk","market":"us","size":26870}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-01-02 13:00","pubTimestamp":1767330000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20514403","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025119894-APUS","pdf_url":"","pub_time":1765342800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/0001213900-25-119894-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119894/ea0268648-8k_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0268648-8k_apimeds.htm","type":"8-K","id":"NTFILE4bxxAno9wVTcRunj","market":"us","size":22019}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-12-10 13:00","pubTimestamp":1765342800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20514397","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025119893-APUS","pdf_url":"","pub_time":1765342800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K/A - Current report: [Amend]","symbol":"APUS","title":"Form 8-K/A - Current report: [Amend]","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/0001213900-25-119893-index.htm","us_notice_code":"Form 8-K/A","us_title_en":"Form 8-K/A - Current report: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/ea0268649-8ka1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0268649-8ka1_apimeds.htm","type":"8-K/A","id":"NTFILEFuFeXBnC8h39uVrT","market":"us","size":38321},{"description":"AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHA","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/ea026864901ex2-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026864901ex2-1_apimeds.htm","type":"EX-2.1","id":"NTFILE4DaVBPD6pyvqh8fJ","market":"us","size":470719},{"description":"CERTIFICATE OF CORRECTION TO CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/ea026864901ex3-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026864901ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILE7G4TCSXWLCMcUXtR","market":"us","size":7834},{"description":"AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT DATED DECEMBER 8, 2025 BY AND B","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025119893/ea026864901ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026864901ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILE8S5QTaUYdVbXHXuQ","market":"us","size":22402}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-12-10 13:00","pubTimestamp":1765342800,"title_zh":"Form 8-K/A - Current report: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20479272","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025117176-APUS","pdf_url":"","pub_time":1764651600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 425 - Prospectuses and communications, business combinations","symbol":"APUS","title":"Form 425 - Prospectuses and communications, business combinations","titleType":"Business Combinations","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/0001213900-25-117176-index.htm","us_notice_code":"Form 425","us_title_en":"Form 425 - Prospectuses and communications, business combinations","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea0267807-8k425_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0267807-8k425_apimeds.htm","type":"425","id":"NTFILE9rQhvKYqYcAn6HNq","market":"us","size":99345},{"description":"AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHA","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex2-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex2-1_apimeds.htm","type":"EX-2.1","id":"NTFILEAemMZkjRsuzW2XWn","market":"us","size":467002},{"description":"CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK, AS FILED WIT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex3-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILEHFCxmwtv6dqY4VDu","market":"us","size":33204},{"description":"FORM OF NOTE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEH4MBk71gu2mRYMQ9","market":"us","size":254303},{"description":"WARRANT ISSUED TO E.F. HUTTON & CO. LLC, DATED DECEMBER 1, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex4-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-2_apimeds.htm","type":"EX-4.2","id":"NTFILE53LnuA1NnbVYp26s","market":"us","size":114309},{"description":"ACQUIROR SUPPORT AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHARM","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILE87exrBV9W1UYxvTW","market":"us","size":76051},{"description":"SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PH","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILEAMUxGpUpesyggLMB","market":"us","size":355963},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILE37ecYDuxBcWe5oBa","market":"us","size":172450},{"description":"FORM OF VOTING AGREEMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex10-4_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-4_apimeds.htm","type":"EX-10.4","id":"NTFILEHQJ3r6NdRBDs4B4D","market":"us","size":28610},{"description":"PRESS RELEASE, DATED DECEMBER 1, 2025","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117176/ea026780701ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILEGBTvjSG1PhuF2rCF","market":"us","size":22873}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Business Combinations","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Business Combinations","pubTime":"2025-12-02 13:00","pubTimestamp":1764651600,"title_zh":"Form 425 - Prospectuses and communications, business combinations","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20479258","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025117173-APUS","pdf_url":"","pub_time":1764651600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/0001213900-25-117173-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AGREEMENT AND PLAN OF MERGER, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHA","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex2-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026780701ex2-1_apimeds.htm","type":"EX-2.1","id":"NTFILEEG389FrDe8dzf4kg","market":"us","size":467002},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea0267807-8k425_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0267807-8k425_apimeds.htm","type":"8-K","id":"NTFILE3noYJLNUrgWgnwyZ","market":"us","size":107188},{"description":"CERTIFICATE OF DESIGNATION OF SERIES A CONVERTIBLE PREFERRED STOCK, AS FILED WIT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex3-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILE6QXWFUMqW29aPJB9","market":"us","size":33204},{"description":"FORM OF NOTE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEEqKU5UR8S9U8BqGG","market":"us","size":254303},{"description":"WARRANT ISSUED TO E.F. HUTTON & CO. LLC, DATED DECEMBER 1, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex4-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex4-2_apimeds.htm","type":"EX-4.2","id":"NTFILEDWaWK18dhobHfwWp","market":"us","size":114309},{"description":"ACQUIROR SUPPORT AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PHARM","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEEPSkr1v9J7eKNWoz","market":"us","size":76051},{"description":"SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 1, 2025, BY AND BETWEEN APIMEDS PH","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILEGdKXYKyyZ4WQ3tDa","market":"us","size":355963},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILE9EHk7mEQnWVZqiHQ","market":"us","size":172450},{"description":"FORM OF VOTING AGREEMENT","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex10-4_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex10-4_apimeds.htm","type":"EX-10.4","id":"NTFILE5wqMf8ndaqGUKhke","market":"us","size":28610},{"description":"PRESS RELEASE, DATED DECEMBER 1, 2025","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025117173/ea026780701ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026780701ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILE85coqPEBeDXKCWTt","market":"us","size":22873}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-12-02 13:00","pubTimestamp":1764651600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.01: Completion of Acquisition or Disposition of Assets;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.01: Changes in Control of Registrant;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20426913","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025112184-APUS","pdf_url":"","pub_time":1763503060000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-112184-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT, DATED NOVEMBER 13, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025112184/ea026616601ex10-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026616601ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEGawRTNKw4kvbaYcC","market":"us","size":10061},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025112184/ea0266166-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0266166-8k_apimeds.htm","type":"8-K","id":"NTFILEDfr1WG9zawSJPh81","market":"us","size":24427}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-11-19 05:57","pubTimestamp":1763503060,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20400506","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025109280-APUS","pdf_url":"","pub_time":1762923600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/0001213900-25-109280-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea0264386-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0264386-10q_apimeds.htm","type":"10-Q","id":"NTFILEHyqe94raUy3Fo4nY","market":"us","size":576092},{"description":"WARRANT ISSUED TO MURDOCK CAPITAL PARTNERS CORP., DATED AUGUST 5, 2025","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILEB9qZxrxBsEfqCwUX","market":"us","size":63202},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILEDgi8v28Pu5EBXnn4","market":"us","size":15933},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILEHoju1QdxYFKxjXTD","market":"us","size":10335},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILE62f9Ly5MMJmENwKq","market":"us","size":3473},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025109280/ea026438601ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea026438601ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILE6NrMmj5jZN9ZfCk7","market":"us","size":3619}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-11-12 13:00","pubTimestamp":1762923600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20273049","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025099553-APUS","pdf_url":"","pub_time":1760587200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/0001213900-25-099553-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FIRST AMENDMENT TO BYLAWS DATED OCTOBER 15, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea026154301ex3-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea026154301ex3-1_apimeds.htm","type":"EX-3.1","id":"NTFILEjwRyGFcMT7FBfCmZ","market":"us","size":2276},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025099553/ea0261543-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0261543-8k_apimeds.htm","type":"8-K","id":"NTFILEFjqKdffHFirbA9gJ","market":"us","size":23620}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-10-16 12:00","pubTimestamp":1760587200,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20010168","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025078507-APUS","pdf_url":"","pub_time":1755576000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/0001213900-25-078507-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea0251232-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0251232-10q_apimeds.htm","type":"10-Q","id":"NTFILE2XrgMFFKD7rRNHHL","market":"us","size":547565},{"description":"AMENDMENT TO MAY 2024 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS US,","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILE9cJyFDVkP5trf7gP","market":"us","size":5457},{"description":"AMENDMENT TO AUGUST 2024 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-2_apimeds.htm","type":"EX-10.2","id":"NTFILE72chVnRndzh9Zb7k","market":"us","size":6143},{"description":"AMENDMENT TO MARCH 2025 PROMISSORY NOTE BY AND BETWEEN APIMEDS PHARMACEUTICALS U","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex10-3_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex10-3_apimeds.htm","type":"EX-10.3","id":"NTFILEAc9Lfp16GVtTq5Y9","market":"us","size":6120},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE7DCEq8fcBhh8gJgP","market":"us","size":9313},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE2vD74iKgKvB1MTTo","market":"us","size":9315},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILEH5X43EKFuZoiruKx","market":"us","size":3231},{"description":"CERTIFICATION","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025078507/ea025123201ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea025123201ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILECY2mG11YmP9kowKU","market":"us","size":3241}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-08-19 12:00","pubTimestamp":1755576000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19882994","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025064446-APUS","pdf_url":"","pub_time":1752638400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/0001213900-25-064446-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE DATED JULY 15, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/ea024916001ex99-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024916001ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILEmN3fT5MbimsCQjYQ","market":"us","size":12075},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/ea0249160-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0249160-8k_apimeds.htm","type":"8-K","id":"NTFILE3bvxq9nAhmqS5h4s","market":"us","size":26453}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-07-16 12:00","pubTimestamp":1752638400,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19739711","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025051567-APUS","pdf_url":"","pub_time":1749096000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025051567/0001213900-25-051567-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025051567/ea024484201-8k_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024484201-8k_apimeds.htm","type":"8-K","id":"NTFILE8odsqxzEQdrP2LhW","market":"us","size":25286}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-06-05 12:00","pubTimestamp":1749096000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19690639","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025047373-APUS","pdf_url":"","pub_time":1747972800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"APUS","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"Employee Stock Ownership","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/0001213900-25-047373-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea0242959-s8_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0242959-s8_apimeds.htm","type":"S-8","id":"NTFILE52LggoZe9FSSHnne","market":"us","size":53045},{"description":"OPINION OF NELSON MULLINS RILEY & SCARBOROUGH LLP AS TO THE LEGALITY OF THE SECU","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex5-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex5-1_apimeds.htm","type":"EX-5.1","id":"NTFILEGbtC3PY5TFp9DAnt","market":"us","size":12212},{"description":"CONSENT OF KREIT & CHIU CPA LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex23-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex23-1_apimeds.htm","type":"EX-23.1","id":"NTFILEASjHarz4gRW42xs2","market":"us","size":2030},{"description":"FILING FEE TABLE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ea024295901ex-fee_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024295901ex-fee_apimeds.htm","type":"EX-FILING FEES","id":"NTFILE6zTmXzxE3Fdy9iq7","market":"us","size":10134},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025047373/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE4FaMqqBxBSTTBAuz","market":"us","size":2814}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Employee Stock Ownership","pubTime":"2025-05-23 12:00","pubTimestamp":1747972800,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19671159","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025045643-APUS","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/0001213900-25-045643-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM OF AMENDMENT TO PROMISSORY NOTE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701ex10-1_apimed.htm","primary":true,"translateUrl":"","linkName":"ea024276701ex10-1_apimed.htm","type":"EX-10.1","id":"NTFILEGXcXLPzK3PfgAAB9","market":"us","size":5177},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701-8k_apimed.htm","primary":false,"translateUrl":"","linkName":"ea024276701-8k_apimed.htm","type":"8-K","id":"NTFILECf2xaduGGxzYw5xW","market":"us","size":25001}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19671158","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025045588-APUS","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"APUS","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/0001213900-25-045588-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea0241519-10q_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0241519-10q_apimeds.htm","type":"10-Q","id":"NTFILEEEU2rwaciswP2wSB","market":"us","size":354005},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE6vfDEW92ghBCzDGe","market":"us","size":10274},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE5P147gtvb7K1qznN","market":"us","size":10279},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex32-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex32-1_apimeds.htm","type":"EX-32.1","id":"NTFILE4kZhUNEJuEFWosf4","market":"us","size":3789},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025045588/ea024151901ex32-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024151901ex32-2_apimeds.htm","type":"EX-32.2","id":"NTFILE5FFDFRBmgG3oeLoF","market":"us","size":3801}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19631585","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025042122-APUS","pdf_url":"","pub_time":1747022400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"APUS","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/0001213900-25-042122-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED MAY 8, 2025, BETWEEN THE COMPANY AND D. BORAL CAPI","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex1-1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea024171101ex1-1_apimeds.htm","type":"EX-1.1","id":"NTFILEEuWUTJ5frmpR5i91","market":"us","size":471273},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea0241711-8k_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea0241711-8k_apimeds.htm","type":"8-K","id":"NTFILE3PRgPNmrXnQw9kdc","market":"us","size":28114},{"description":"REPRESENTATIVE'S WARRANTS, DATED MAY 12, 2025, TO JOSEPH T. RALLO","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex4-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex4-1_apimeds.htm","type":"EX-4.1","id":"NTFILED2mbjCPZrUmANpp2","market":"us","size":118449},{"description":"FORM OF INDEMNIFICATION AGREEMENT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex10-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex10-1_apimeds.htm","type":"EX-10.1","id":"NTFILEBJGf68uce4xmdQah","market":"us","size":99414},{"description":"PRESS RELEASE, DATED MAY 8, 2025","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex99-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex99-1_apimeds.htm","type":"EX-99.1","id":"NTFILE93jEdW79RkCDHFR4","market":"us","size":13261},{"description":"PRESS RELEASE, DATED MAY 12, 2025","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025042122/ea024171101ex99-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024171101ex99-2_apimeds.htm","type":"EX-99.2","id":"NTFILEDjSHWbmn3WfmsWgi","market":"us","size":10936}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-05-12 12:00","pubTimestamp":1747022400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19928808","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025039670-APUS","pdf_url":"","pub_time":1746474573000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-039670-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025039670/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE88uf2DtjWMwsCasn","market":"us","size":5769}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-05-06 03:49","pubTimestamp":1746474573,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19928885","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025039664-APUS","pdf_url":"","pub_time":1746474474000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"APUS","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1894525/0001213900-25-039664-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025039664/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8Qg1ZfdBwPitc8qR","market":"us","size":6205}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-05-06 03:47","pubTimestamp":1746474474,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19594720","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025038644-APUS","pdf_url":"","pub_time":1746158400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","symbol":"APUS","title":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","titleType":"[Rev.]Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/0001213900-25-038644-index.htm","us_notice_code":"Form 10-K/A","us_title_en":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 1 TO FORM 10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea0240523-10ka1_apimeds.htm","primary":true,"translateUrl":"","linkName":"ea0240523-10ka1_apimeds.htm","type":"10-K/A","id":"NTFILEDRwCD4wiaJrBbEoc","market":"us","size":72679},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea024052301ex31-1_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024052301ex31-1_apimeds.htm","type":"EX-31.1","id":"NTFILE7ckuwFxfaJAQTkKV","market":"us","size":9548},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025038644/ea024052301ex31-2_apimeds.htm","primary":false,"translateUrl":"","linkName":"ea024052301ex31-2_apimeds.htm","type":"EX-31.2","id":"NTFILE8XWnmRSrLZE8AKLz","market":"us","size":9560}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"[Rev.]Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"[Rev.]Annual Report","pubTime":"2025-05-02 12:00","pubTimestamp":1746158400,"title_zh":"Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}